Injective is the developer of a decentralized exchange protocol for derivatives, aimed at establishing a free and inclusive financial system. Their protocol leverages cryptographic research on verifiable delay functions to remove front-running and facilitate trustless liquidity sharing. This assists clients in tackling key security vulnerabilities and scalability issues inherent in decentralized exchanges.

Investors Include:

The Cabin Capital, Chorus One, BoxOne Ventures, Pnyx Ventures, GravityX Capital, Ellipti, Binance, NFVentures, Pantera Capital, Cadenza Capital, K42, Innovating Capital, Infinity Capital (Vietnam), ZBS Capital, AU21 Capital, QCP Soteria, Figment Capital, Krypital Group, BlockTower Capital, Axia8 Ventures, Black Mamba Ventures, Drops Ventures, QCP Capital, West Labs, StartX (US).

Looking to sell Injective Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you